Medical research will be translated into technologies to improve healthcare as part of a new collaboration between Chinese researchers and the University of Edinburgh. The Biomedical Translational Research Centre at Haining in Zhejiang province will be developed in association with the Zhejiang University – University of Edinburgh Institute. The centre will create commercial products and develop new ideas for innovative care. A memorandum of understanding...
A CHANCE connection between Ayrshire farmer Bryce Cunningham and a Lanarkshire biotech company has sparked a quest to create the world’s first compostable single use milk bottle, using a natural biopolymer made from langoustine shells. CuanTec, which is based at the Life Sciences hub, MediCity, near Motherwell, has already devised a revolutionary way to produce plastic food wrap from crustacean shells on an industrial scale, and scientists...
Ubiquigent and Forma Therapeutics have entered into a multi-year strategic research and development (R&D) collaboration agreement for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will design novel DUB inhibitors and evaluate them using its biology platform. During this term, Forma will have exclusive access and an option for a worldwide licence to all compounds...
A collaborative partnership between academic and industrial institutions in the UK, Finland, Germany, Greece and the Netherlands, the network will be run from Glasgow’s Cancer Research UK Beatson Institute, one of the U.K.’s leading cancer research establishments. The four-year Translational Research Network for Prostate Cancer (TransPot) aims to provide a multidisciplinary training program, integrating cancer biology and systems medicine to enable young researchers to become...
Health Data Research UK is awarding £30 million funding to six sites across the UK, including Scotland, to address challenging healthcare issues through use of data science. Each site has world-class expertise; a track record in using health data to derive new knowledge, scientific discovery and insight; and works in close partnership with NHS bodies and the public to translate research findings into benefits for...
A life sciences spin-out from the University of Strathclyde has announced the appointment of Mitch Scanlan as their new chief executive. Scanlan takes over from Biogelx founder, David Lightbody, who stood down as Chief Executive at the beginning of January to focus on the commercialisation of the start-up’s 3D biomaterial technology platform. Read the full story here.